carbon monoxide has been researched along with Sarcoidosis in 26 studies
Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.
Sarcoidosis: An idiopathic systemic inflammatory granulomatous disorder comprised of epithelioid and multinucleated giant cells with little necrosis. It usually invades the lungs with fibrosis and may also involve lymph nodes, skin, liver, spleen, eyes, phalangeal bones, and parotid glands.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thirty-nine sarcoidosis patients with pulmonary infiltrations (stage II) of less than 5 years duration and not treated earlier with corticosteroids were randomly allocated for treatment with methylprednisolone for 7 months or for observation without therapy." | 5.04 | Corticosteroid therapy of pulmonary sarcoidosis. A prospective evaluation of alternate day and daily dosage in stage II disease. ( Sellergren, TL; Selroos, O, 1979) |
| "Sarcoidosis is a systemic inflammatory disease characterized by non-necrotizing granulomas in involved organs, most commonly the lung." | 1.46 | Clinical and Biological Insights from the University of California San Francisco Prospective and Longitudinal Cohort. ( Arger, NK; Benn, BS; Gelfand, JM; Gomez, A; Ho, M; Kidd, SA; Koth, LL; Lehman, Z; Nguyen, CP; Ramstein, J; Su, R; Sun, S, 2017) |
| "Sarcoidosis is a systemic granulomatous disease with predominant manifestation in the lungs, often presenting as interstitial lung disease." | 1.36 | Impaired lung compliance and DL,CO but no restrictive ventilatory defect in sarcoidosis. ( Boros, PW; Borsboom, GJ; Enright, PL; Hyatt, RE; Quanjer, PH; Wesolowski, SP, 2010) |
| "Pulmonary hypertension was found in 34." | 1.36 | [Sarcoidosis. Clinical presentation and prognosis]. ( Cáneva, J; González, EL; Vigliano, C, 2010) |
| "Sarcoidosis is a systemic granulomatous disease of unknown etiology characterized by activation of macrophages and T lymphocytes." | 1.35 | The analysis of tryptase in serum of sarcoidosis patients. ( Bargagli, E; Bianchi, N; Mazzi, A; Mezzasalma, F; Olivieri, C; Perrone, A; Pieroni, MG; Prasse, A; Rottoli, P, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (65.38) | 18.7374 |
| 1990's | 1 (3.85) | 18.2507 |
| 2000's | 4 (15.38) | 29.6817 |
| 2010's | 4 (15.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benn, BS | 1 |
| Lehman, Z | 1 |
| Kidd, SA | 1 |
| Ho, M | 1 |
| Sun, S | 1 |
| Ramstein, J | 1 |
| Arger, NK | 1 |
| Nguyen, CP | 1 |
| Su, R | 1 |
| Gomez, A | 1 |
| Gelfand, JM | 1 |
| Koth, LL | 1 |
| Öztürk, A | 1 |
| Kayacan, O | 1 |
| Bargagli, E | 1 |
| Mazzi, A | 1 |
| Mezzasalma, F | 1 |
| Perrone, A | 1 |
| Olivieri, C | 1 |
| Prasse, A | 1 |
| Bianchi, N | 1 |
| Pieroni, MG | 1 |
| Rottoli, P | 1 |
| Boros, PW | 1 |
| Enright, PL | 1 |
| Quanjer, PH | 1 |
| Borsboom, GJ | 1 |
| Wesolowski, SP | 1 |
| Hyatt, RE | 1 |
| González, EL | 1 |
| Vigliano, C | 1 |
| Cáneva, J | 1 |
| Sato, H | 1 |
| Grutters, JC | 1 |
| Pantelidis, P | 1 |
| Mizzon, AN | 1 |
| Ahmad, T | 1 |
| Van Houte, AJ | 1 |
| Lammers, JW | 1 |
| Van Den Bosch, JM | 1 |
| Welsh, KI | 1 |
| Du Bois, RM | 1 |
| BEUMER, HM | 1 |
| JOHNSON, RL | 1 |
| TAYLOR, HF | 1 |
| DEGRAFF, AC | 1 |
| WOOLF, CR | 1 |
| Rutherford, RM | 1 |
| Brutsche, MH | 1 |
| Kearns, M | 1 |
| Bourke, M | 1 |
| Stevens, F | 1 |
| Gilmartin, JJ | 1 |
| Bourbonnais, JM | 1 |
| Samavati, L | 1 |
| Randowa, D | 1 |
| Mookherjee, S | 1 |
| Ashutosh, K | 1 |
| Smulyan, H | 1 |
| Vardan, S | 1 |
| Warner, R | 1 |
| Muir, JF | 1 |
| Levi-Valensi, P | 1 |
| Vonachen, P | 1 |
| Smadja, A | 1 |
| Selroos, O | 2 |
| Grönhagen-Riska, C | 1 |
| Sellergren, TL | 1 |
| Miller, A | 1 |
| Chuang, M | 1 |
| Teirstein, AS | 1 |
| Siltzbach, LE | 1 |
| Salorinne, Y | 1 |
| Sietsma, K | 1 |
| Le Merre, C | 1 |
| Rousset, G | 1 |
| Prefaut, C | 1 |
| Ostrow, D | 1 |
| Cherniack, RM | 1 |
| Lopez-Majano, V | 1 |
| Gracey, DR | 1 |
| Divertie, MB | 1 |
| Brown, AL | 1 |
| Kreukniet, J | 1 |
| Holmgren, A | 1 |
| Svanborg, N | 1 |
| Isawa, T | 1 |
1 trial available for carbon monoxide and Sarcoidosis
| Article | Year |
|---|---|
Corticosteroid therapy of pulmonary sarcoidosis. A prospective evaluation of alternate day and daily dosage in stage II disease.
Topics: Carbon Monoxide; Female; Follow-Up Studies; Forced Expiratory Volume; Humans; Lung Diseases; Male; M | 1979 |
25 other studies available for carbon monoxide and Sarcoidosis
| Article | Year |
|---|---|
Clinical and Biological Insights from the University of California San Francisco Prospective and Longitudinal Cohort.
Topics: Adult; Age Factors; Aged; Black or African American; Carbon Monoxide; Case-Control Studies; Cohort S | 2017 |
Rising stars of DPLD survival: FVC and exercise desaturation (a single-center study)
Topics: Age Factors; Aged; Blood Pressure; Carbon Monoxide; Connective Tissue Diseases; Exercise; Exercise T | 2018 |
The analysis of tryptase in serum of sarcoidosis patients.
Topics: Adult; Biomarkers; Bronchoalveolar Lavage Fluid; Bronchoscopy; Carbon Monoxide; Case-Control Studies | 2009 |
Impaired lung compliance and DL,CO but no restrictive ventilatory defect in sarcoidosis.
Topics: Adult; Carbon Monoxide; Female; Humans; Lung; Lung Compliance; Lung Diseases, Interstitial; Male; Mi | 2010 |
[Sarcoidosis. Clinical presentation and prognosis].
Topics: Adult; Aged; Argentina; Carbon Monoxide; Female; Follow-Up Studies; Humans; Hypertension, Pulmonary; | 2010 |
HLA-DQB1*0201: a marker for good prognosis in British and Dutch patients with sarcoidosis.
Topics: Adaptor Proteins, Signal Transducing; Alleles; ATP-Binding Cassette Transporters; Carbon Monoxide; D | 2002 |
DETERMINATION OF THE TRANSFER FACTOR AND HALF TIME OF CARBON MONOXIDE DURING APNEA IN THE HUMAN LUNGS IN NORMAL AND PATHOLOGICAL CASES.
Topics: Apnea; Blood Gas Analysis; Carbon Monoxide; Humans; Lung Diseases; Pathology; Physical Exertion; Pul | 1964 |
FUNCTIONAL SIGNIFICANCE OF A LOW PULMONARY DIFFUSING CAPACITY FOR CARBON MONOXIDE.
Topics: Altitude; Capillaries; Carbon Monoxide; Cell Membrane Permeability; Oximetry; Physical Exertion; Pul | 1965 |
THE RELATIONSHIPS BETWEEN MINUTE VENTILATION, PULMONARY GAS DIFFUSION AND RESPIRATORY WORK MEASURED SIMULTANEOUSLY DURING A STANDARD EXERCISE TEST.
Topics: Bronchial Diseases; Bronchiectasis; Bronchitis; Carbon Monoxide; Cystic Fibrosis; Eosinophilic Granu | 1965 |
HLA-DR2 predicts susceptibility and disease chronicity in Irish sarcoidosis patients.
Topics: Adult; Biomarkers; Carbon Monoxide; Case-Control Studies; Chronic Disease; Female; Follow-Up Studies | 2004 |
Clinical predictors of pulmonary hypertension in sarcoidosis.
Topics: Adult; Carbon Monoxide; Echocardiography; Exercise Test; Female; Humans; Hypertension, Pulmonary; Ma | 2008 |
[Disturbances in diffusion in chronic pulmonary diseases (Carbon monoxide method)].
Topics: Adolescent; Adult; Aged; Carbon Monoxide; Female; Humans; Lung Diseases; Male; Middle Aged; Pulmonar | 1967 |
Arterial oxygenation and pulmonary function with Saralasin in chronic lung disease.
Topics: Adult; Aged; Angiotensin II; Carbon Dioxide; Carbon Monoxide; Cardiac Output; Forced Expiratory Volu | 1983 |
Significance of carbon monoxide pulmonary partial ductances and transbronchial lung biopsies during evolution of interstitial lung diseases.
Topics: Asbestosis; Biopsy; Bird Fancier's Lung; Bronchitis; Bronchoscopy; Carbon Monoxide; Humans; Lung; Lu | 1980 |
Angiotensin converting enzyme. III. Changes in serum level as an indicator of disease activity in untreated sarcoidosis.
Topics: Adult; Aged; Carbon Monoxide; Female; Humans; Lung; Male; Middle Aged; Muramidase; Peptidyl-Dipeptid | 1979 |
Pulmonary function in stage I and II pulmonary sarcoidosis.
Topics: Airway Resistance; Carbon Monoxide; Forced Expiratory Volume; Humans; Lung; Lung Diseases; Maximal M | 1976 |
Single-breath pulmonary diffusing capacity. Reference values and application in connective tissue diseases and in various lung diseases.
Topics: Adult; Aged; Arthritis, Rheumatoid; Biopsy, Needle; Carbon Monoxide; Collagen Diseases; Female; Hemo | 1976 |
Sarcoidosis and the diffusing capacity for carbon monoxide.
Topics: Carbon Monoxide; Humans; Pulmonary Diffusing Capacity; Sarcoidosis | 1990 |
[Underestimation of bronchial obstruction in sarcoidosis].
Topics: Adult; Airway Resistance; Carbon Monoxide; Female; Humans; Lung Compliance; Lung Volume Measurements | 1986 |
Resistance to airflow in patients with diffuse interstitial lung disease.
Topics: Aged; Airway Resistance; Carbon Monoxide; Female; Humans; Lung; Lung Compliance; Male; Middle Aged; | 1973 |
Diffusing capacity in pulmonary fibrosis, sarcoidosis and bronchogenic carcinoma.
Topics: Bronchial Neoplasms; Bronchodilator Agents; Carbon Monoxide; Carcinoma, Bronchogenic; Humans; Pulmon | 1972 |
Alveolar-capillary membrane in pulmonary sarcoidosis: an electron microscopic study.
Topics: Adult; Biopsy; Capillaries; Carbon Monoxide; Cell Membrane; Female; Humans; Lung; Lung Diseases; Mal | 1972 |
Relation between rebreathing CO-diffusing capacity of the lung and unequal ventilation.
Topics: Adult; Aged; Carbon Dioxide; Carbon Monoxide; Chronic Disease; Diffusion; Female; Helium; Humans; Lu | 1970 |
On the influence of body position on steady-state diffusing capacity during exercise, studied in patients with pulmonary sarcoidosis.
Topics: Adult; Carbon Monoxide; Exercise Test; Female; Humans; Lung Diseases; Lung Neoplasms; Lymphoma; Male | 1966 |
Studies on the distribution of the pulmonary arterial blood flow in the lungs by radioisotope scanning. IV. Pulmonary sarcoidosis: the distribution of the pulmonary arterial blood flow with special reference to pulmonary function.
Topics: Adolescent; Adult; Carbon Monoxide; Child; Female; Humans; Lung Diseases; Male; Pulmonary Artery; Pu | 1966 |